Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study

Cheol Chung, Hyun; Ros, Willeke; Delord, Jean‐Pierre; Perets, Ruth; Italiano, Antoîne; Shapira‐Frommer, Ronnie; Manzuk, Lyudmila; A. Piha‐Paul, Sarina; Xu, Lei; Zeigenfuss, Susan; K. Pruitt, Scott; Léary, Alexandra

doi:10.1200/jco.18.01265

Public

Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study

Published in Journal of Clinical Oncology • Apr 3, 2019

Authors:

Hyun Cheol Chung

Willeke Ros

Jean‐Pierre Delord

Abstract

PURPOSE: KEYNOTE-158 ( ClinicalTrials.gov identifier: NCT02628067) is a phase II basket study investigating the antitumor activity and safety of pembrolizumab in multiple cancer types. We present interim results from patients with previously treated advanced cervical cancer. PATIENTS AND METHODS: Pa...

Subject

Medicine

Pembrolizumab

Cervical cancer

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!